Enfermedad Pulmonar Obstructiva Cronica

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 13

ENFERMEDAD PULMONAR

OBSTRUCTIVA CRONICA
MIP KARLA CORTÉS
DEFINICION

• ENFERMEDAD FRECUENTE, PREVENIBLE Y TRATABLE ANOMALIAS DE VIAS


• SINTOMAS RESPIRATORIOS
RESPIRATORIAS O
ALVEOLARES
• LIMTACION DEL FLUJO AEREO PERSISTENTE • vias aereas pequeñas
• destruccion del
parenquima

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
ETIOLOGIA

CONTAMINACION EXPOSICION COMBUSTIBLES


TABAQUISMO
ATMOSFERICA LABORAL BIOMASA

GENETICA MAL
HIPERSENSIBILID
DESARROLLO INFECCIONES
AAT AD DE VA
PULMONAR

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
DIAGNOSTICO

DIFERENCIAL:
• ASMA
• INSUFICIENCIA CARDIACA CONGESTIVA
• BRONQUIECTASIAS
• TB
• BRONQUIOLITIS OBLITERANTE

Gold Initiative for Chronic Obstructive Lung Disease.


Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease.
NHLBI/WHO Workshop Report (2017)
EVALUACION Y CLASIFICACION

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
ESPIROMETRIA

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
RX DE TORAX
TRATAMIENTO

• MEDIDAS EN TTO
• DEJAR DE FUMAR
• VACUNAS
• ANTIGRIPAL
• NEUMOCOCICA (REDUCE NEUMONIA)
• BRONCODIL NO DE ACCION CORTA (LABA (SALMETEROL Y
FORMOTEROL 2XDIA))
• ANTIMUSC TIOTROPIO
• METILXANTINAS
• CORTICOESTEROIDES

Gold Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and
Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report (2017)
EPOC ESTABLE
National Institute for Clinical Excellence. Chronic obstructive pulmonary disease. Management of
chronic obstructive pulmonary disease in adults in primary and secondary care. Quick reference
guide 2004.

OXIGENO

• Pacientes con paO2 <55 mmHg respirando aire


ambiente
• paO2 entre 56 y 59 mmHg con signos de HTP
• Insuficiencia cardiaca congestiva
• Arritmias
• Edema periférico
• Hematocrito mayor al 55%.

• La ATS/ERS3 y la NICE4 recomiendan su


administración en pacientes
• Desaturaciones nocturnas >30% del sueño

You might also like